MOTTA, IRENE
MOTTA, IRENE
Dipartimento di Scienze Cliniche e di Comunità
How I manage luspatercept in transfusion-dependent beta-thalassemia
2026 D.L. Panzieri, N. Scaramellini, S. Leoni, A. Taher, M.D. Cappellini, I. Motta
Atrial fibrillation prevalence and its management in aging, transfusion-dependent patients with thalassemia: the FATHAL study
2026 V. Di Stefano, B. Gianesin, V. Orecchia, F. Longo, S. Barella, A. Barone, M. Culcasi, A.R. Denotti, S. Costantini, F. Ferrara, I. Foggetti, A. Gigante, M.R. Manca, F. Mazzi, A. Pasanisi, M. Pisaniello, P. Ricchi, M. Serra, R. Origa, M. Bertini, I. Motta
An adult patient with incidentally detected bilateral ground-glass opacities
2026 J. Cefalo, M. Degrassi, G. Carone, N. Scaramellini, M. Zava, A. Moro, U. Gianelli, I. Motta, M. Mondoni
EHA Recommendations for preconceptual and antenatal screening and prenatal diagnosis for hemoglobinopathies
2026 M. De Montalembert, M.D. Cappellini, A. Iolascon, L. De Franceschi, E. Ömur, M. Abi Saad, I. Andolfo, C. Bento, M. Berghs, D. Bonnet, A. Glenthoj, B. Gulbis, T.K. Dolai, J. Lima, I. Motta, R. Russo, A. Taher, L. Tshilolo, A. Almeida, D. Rees
Impact of cardiac magnetic resonance on the clinical management of patients with Fabry disease: Data from the CMR Italian research and CLinical nEtwork for Fabry disease (CIRCLE-FD)
2026 A. Camporeale, G. De Angeli, G. Guida, F. Pieruzzi, L. Econimo, P. Lusardi, I. Motta, R. Mignani, M. Spada, M. Pieroni, M. Canepa, Y. Battaglia, F. Graziani, M. Rubino, S. Caruso, S. Piga, C. Lanzillo, I. Simonetta, C.A. Inserra, A. Bersano, S. Boveri, A. Attanasio, G. Disabato, L. Tondi, P. Spagnolo, M. Piepoli, G. Carrafiello, M. Lombardi
A Case of Hodgkin Lymphoma in a Gaucher Disease Patient: Distinguishing Gaucher and Pseudo-Gaucher Cells
2025 N. Scaramellini, M. Canzi, E. Cassinerio, M. Migone De Amicis, L. Pettine, B. Fattizzo, F.G. Rossi, G. Croci, I. Motta
Luspatercept for Transfusion-Dependent Beta-Thalassemia: Real-World Experience in a Large Cohort of Patients From Italy
2025 R. Origa, B. Gianesin, A. Zappu, A.R. Denotti, M.A. Di Giorgio, R. Sciortino, I. Motta, D.L. Panzieri, R. Rosso, A. Bulla, M. Culcasi, A.M. Pasanisi, L. De Franceschi, R. Di Maggio, V.M. Pinto, P.M.G. Sanna, P. Ricchi, G.B. Ruffo, F. Schieppati, D. Roberti, G.B. Ferrero, E. De Michele, F. Arcioni, I. Fotzi, S. Marktel, A. Poloni, G. Soverini, E.R. Testa, G. Cabiddu, C. Fortugno, A. Gigante, F. Polese, D. Rapezzi, A. Sau, G.L. Forni, M.D. Cappellini, F. Longo
Thalassemia and hypercoagulability
2025 M.D. Cappellini, A.T. Taher, I. Motta
Iron Chelation Therapy
2025 M.D. Cappellini, N. Scaramellini, S. Leoni, I. Motta
Understanding and targeting erythroid cell metabolism
2025 M. Ni, N. Scaramellini, I. Motta, J. Xu
Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease
2024 I. Motta, P. Delbini, N. Scaramellini, V. Ghiandai, L. Duca, I. Nava, F. Nascimbeni, S. Lugari, D. Consonni, E. Trombetta, V. Di Stefano, M. Migone De Amicis, E. Cassinerio, F. Carubbi, M.D. Cappellini
A glutamine metabolic switch supports erythropoiesis
2024 J. Lyu, Z. Gu, Y. Zhang, H.S. Vu, C. Lechauve, F. Cai, H. Cao, J. Keith, V. Brancaleoni, F. Granata, I. Motta, M.D. Cappellini, L.J. Huang, R.J. Deberardinis, M.J. Weiss, M. Ni, J. Xu
Step out of the shadows: a call for action for rare diseases
2024 F. Granata, R. Bou Fakhredin, M.D. Cappellini, I. Motta
Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia
2024 S. Leoni, R. Bou Fakhredin, F. Granata, E. Cassinerio, M. Maggioni, A.L. Fracanzani, M.D. Cappellini, I. Motta
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with transfusion-dependent β-thalassemia
2024 D.L. Panzieri, D. Consonni, N. Scaramellini, G. Ausenda, F. Granata, N. Caponio, L. Duca, S. Leoni, S. Elli, M. Ferraresi, V. Bolis, C. Curcio, M.A. Irrera, D. Maira, G. Graziadei, E. Cassinerio, M.D. Cappellini, R. Bou-Fakhredin, V. Brancaleoni, I. Motta
Deciphering cytopenias in internal medicine: a single-center observational study
2024 S. Leoni, M. Ferraresi, I. Motta, C. Hu, A.L. Fracanzani, W. Barcellini, B. Fattizzo
Decrease in Hemoglobin Levels during Acute Attacks in Patients with Idiopathic Recurrent Pericarditis: A Model of Anemia in Acute Disease
2024 F. Casarin, R. Mascolo, I. Motta, M.A. Wu, E. Bizzi, A. Pedroli, G. Dieguez, G. Iacomelli, L. Serati, L. Duca, S. Maestroni, E. Tombetti, M.D. Cappellini, A. Brucato
Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease
2023 M. Ferraresi, D.L. Panzieri, S. Leoni, M.D. Cappellini, A. Kattamis, I. Motta
Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia
2023 A. Aprile, L. Raggi, S. Bolamperti, I. Villa, M. Storto, G. Morello, S. Marktel, C. Tripodo, M.D. Cappellini, I. Motta, A. Rubinacci, G. Ferrari
Interpreting Iron Homeostasis in Congenital and Acquired Disorders
2023 N. Scaramellini, D. Fischer, A.R. Agarvas, I. Motta, M.U. Muckenthaler, C. Mertens